Tilray Brands, Inc. has crossed an important threshold toward sustainable earnings and cash discipline. Click for what Class ...

Dr. Clark allegedly bought controlled substances for purposes unrelated to his profession and then kept and dealt the ...

Canopy Growth (CGC) surged 54% after reports Trump may reclassify marijuana to Schedule III. Here’s how tax relief, banking ...

Kang Haggerty LLC is proud to announce that it represented the whistleblower in a False Claims Act (FCA) case that resulted in a $2 million settlement with Recovery Centers of America (RCA). The ...

Amid heightened rumors that the Trump administration will be moving forward on marijuana rescheduling, multiple top ...

A former top state marijuana regulator and current executive at a cannabis consulting firm will participate in a Senate ...

A new definition of hemp with cap on THC per container could halt the burgeoning cannabis beverage if stakeholders don’t ...

Recovery Centers of America pays $2 million to settle allegations of mismanaging controlled substances and subpar treatment ...

The rally marked one of the biggest single-day moves for cannabis stocks in years, snapping a prolonged slump.

The Cannabinoid Safety and Regulation Act (CSRA) aims to regulate hemp-derived beverages in the US by implementing a minimum ...

The organization agrees to pay $2M after federal officials allege violations of the controlled substance laws and false ...

Trump's decision to move marijuana to Schedule III could ease taxes and expand medical access, but industry leaders warn it ...